Price negotiations begin between Chinese officials, drugmakers
Share - WeChat

The latest round of price negotiations between Chinese officials and drugmakers aiming to have their products included on China's medical reimbursement list kicked off on Thursday, the National Healthcare Security Administration said.
Over 100 types of medications are involved in the talks, including therapies for COVID-19 as well as drugs for cancer and rare diseases, the administration said.
The national reimbursement list has been updated ever since the NHSA's establishment in 2018. The list currently contains 2,860 drugs.
As a result of price negotiations, drugs that have been added to the list have seen an average price cut of over 50 percent.
- Shanghai street treasure hunt: A taxi driver speaks 4 languages
- CCG steps up patrols to safeguard maritime rights
- China's longest, most challenging equestrian event kicks off in Xinjiang
- Digital platform reunites Dunhuang artifacts as cave discovery marks 125 years
- Medical aid program brings new life to children with deformities in Chamdo
- Xi's article on building China into leading country in education to be published